Loading…
Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism
One prospective, open-label, non-randomized study was conducted in 100 patients to define the antipyretic and analgesic effect of a new intravenous formulation of 1 g of paracetamol; 71 received paracetamol for the management of fever and 29 received paracetamol for pain relief after abdominal surge...
Saved in:
Published in: | Journal of Pharmacological Sciences 2014/02/20, Vol.124(2), pp.144-152 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c774t-f9ccce017002792a6691bdd5455f7b82c779479d9620e6b5b8ed23c61d12999f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c774t-f9ccce017002792a6691bdd5455f7b82c779479d9620e6b5b8ed23c61d12999f3 |
container_end_page | 152 |
container_issue | 2 |
container_start_page | 144 |
container_title | Journal of Pharmacological Sciences |
container_volume | 124 |
creator | Giamarellos-Bourboulis, Evangelos J. Spyridaki, Aikaterini Savva, Athina Georgitsi, Marianna Tsaganos, Thomas Mouktaroudi, Maria Raftogiannis, Maria Antonopoulou, Anastasia Papaziogas, Vassilios Baziaka, Fotini Sereti, Kalliopi Christopoulos, Petros Marioli, Androniki Kanni, Theodora Maravitsa, Panagiota Pantelidou, Ilianna Leventogiannis, Konstantinos Tsiaoussis, Panagiotis Lymberopoulou, Korina Koutelidakis, Ioannis M. |
description | One prospective, open-label, non-randomized study was conducted in 100 patients to define the antipyretic and analgesic effect of a new intravenous formulation of 1 g of paracetamol; 71 received paracetamol for the management of fever and 29 received paracetamol for pain relief after abdominal surgery or for neoplastic pain. Serial follow-up measurements of core temperature and of pain intensity were done for 6 h. Additional rescue medications were recorded for 5 days. Blood was sampled for the measurement of free paracetamol (APAP) and of glucuronide-APAP and N-sulfate-APAP by an HPLC assay. Defervescence, defined as core temperature below or equal to 37.1°C, was achieved in 52 patients (73.2%) within a median time of 3 h. Patients failing to become afebrile with the first dose of paracetamol became afebrile when administered other agents as rescue medications. Analgesia was achieved in 25 patients (86.4%) within a median time of 2 h. Serum levels of glucuronide-APAP were greater among non-responders to paracetamol. The presented results suggest that the intravenous formulation of paracetamol is clinically effective depending on drug metabolism. |
doi_str_mv | 10.1254/jphs.13133FP |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b521884dbc9d49249b15fe31aeca273b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319301975</els_id><doaj_id>oai_doaj_org_article_b521884dbc9d49249b15fe31aeca273b</doaj_id><sourcerecordid>1837303278</sourcerecordid><originalsourceid>FETCH-LOGICAL-c774t-f9ccce017002792a6691bdd5455f7b82c779479d9620e6b5b8ed23c61d12999f3</originalsourceid><addsrcrecordid>eNqFkc1vFCEYxidGY2v15tnM0YNb-RzAW9PaukmNTdQzYZh3ZtnMwApsk_73sjvbOZnIAd4Xfnl44Kmq9xhdYsLZ5-1uky4xxZTePryozjFlYiUbJl8uNaZn1ZuUtggRiXDzujojjHPKED2vhrXP0TyCD_tUP5hoLGQzhbE2qTa-vvLZ7Z4iZGdL25XejAOk0n2HzlmTXfBf6ryB-qcbvOvLlrdQh76-ifuhQNm0YXRpelu96s2Y4N1pvah-3379df1tdf_jbn19db-yQrC86pW1FhAWxatQxDSNwm3X8eK3F60khVJMqE41BEHT8lZCR6htcIeJUqqnF9V61u2C2epddJOJTzoYp48bIQ7axPKaEXTLCZaSda1VHVOEqRbzHig2YA0RtC1aH2etXQx_9pCynlyyMI7GQ_kujSUVFFEi5P9RjjAVQjZNQT_NqI0hpQj94hIjfUhUHxLVp0QL_uGkvG8n6Bb4OcIC3M3AdExkDH50HvQ27GMJK2nbN8k68JogzDTChCGiEeKlZIeekzKkILwo3cxK25TNAMtVzx82-yJMk-N8crgc242JGnyRaWYZKDk_Ooj6eL8t9iLYXIJw_37qX3Ig3N4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1501377866</pqid></control><display><type>article</type><title>Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism</title><source>ScienceDirect®</source><creator>Giamarellos-Bourboulis, Evangelos J. ; Spyridaki, Aikaterini ; Savva, Athina ; Georgitsi, Marianna ; Tsaganos, Thomas ; Mouktaroudi, Maria ; Raftogiannis, Maria ; Antonopoulou, Anastasia ; Papaziogas, Vassilios ; Baziaka, Fotini ; Sereti, Kalliopi ; Christopoulos, Petros ; Marioli, Androniki ; Kanni, Theodora ; Maravitsa, Panagiota ; Pantelidou, Ilianna ; Leventogiannis, Konstantinos ; Tsiaoussis, Panagiotis ; Lymberopoulou, Korina ; Koutelidakis, Ioannis M.</creator><creatorcontrib>Giamarellos-Bourboulis, Evangelos J. ; Spyridaki, Aikaterini ; Savva, Athina ; Georgitsi, Marianna ; Tsaganos, Thomas ; Mouktaroudi, Maria ; Raftogiannis, Maria ; Antonopoulou, Anastasia ; Papaziogas, Vassilios ; Baziaka, Fotini ; Sereti, Kalliopi ; Christopoulos, Petros ; Marioli, Androniki ; Kanni, Theodora ; Maravitsa, Panagiota ; Pantelidou, Ilianna ; Leventogiannis, Konstantinos ; Tsiaoussis, Panagiotis ; Lymberopoulou, Korina ; Koutelidakis, Ioannis M. ; Second Department of Surgery ; Medical School ; Second Department of Internal Medicine ; University of Athens ; Fourth Department of Internal Medicine ; University of Thessaloniki ; "Sismanogleion" Athens Hospital</creatorcontrib><description>One prospective, open-label, non-randomized study was conducted in 100 patients to define the antipyretic and analgesic effect of a new intravenous formulation of 1 g of paracetamol; 71 received paracetamol for the management of fever and 29 received paracetamol for pain relief after abdominal surgery or for neoplastic pain. Serial follow-up measurements of core temperature and of pain intensity were done for 6 h. Additional rescue medications were recorded for 5 days. Blood was sampled for the measurement of free paracetamol (APAP) and of glucuronide-APAP and N-sulfate-APAP by an HPLC assay. Defervescence, defined as core temperature below or equal to 37.1°C, was achieved in 52 patients (73.2%) within a median time of 3 h. Patients failing to become afebrile with the first dose of paracetamol became afebrile when administered other agents as rescue medications. Analgesia was achieved in 25 patients (86.4%) within a median time of 2 h. Serum levels of glucuronide-APAP were greater among non-responders to paracetamol. The presented results suggest that the intravenous formulation of paracetamol is clinically effective depending on drug metabolism.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.13133FP</identifier><identifier>PMID: 24553403</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>Abdominal Pain - drug therapy ; Acetaminophen - administration & dosage ; Acetaminophen - blood ; Acetaminophen - metabolism ; Acetaminophen - pharmacokinetics ; Adolescent ; Adult ; Aged ; analgesia ; Female ; fever ; Fever - drug therapy ; Fever - etiology ; Humans ; Infection - complications ; Infusions, Intravenous ; Interleukin-6 - blood ; intravenous paracetamol ; Male ; Middle Aged ; pain ; Pain, Intractable - drug therapy ; Pain, Postoperative - drug therapy ; Prospective Studies ; Treatment Outcome ; Young Adult</subject><ispartof>Journal of Pharmacological Sciences, 2014/02/20, Vol.124(2), pp.144-152</ispartof><rights>2014 Elsevier B.V.</rights><rights>2014 The Japanese Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c774t-f9ccce017002792a6691bdd5455f7b82c779479d9620e6b5b8ed23c61d12999f3</citedby><cites>FETCH-LOGICAL-c774t-f9ccce017002792a6691bdd5455f7b82c779479d9620e6b5b8ed23c61d12999f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319301975$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,4010,27900,27901,27902,45756</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24553403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giamarellos-Bourboulis, Evangelos J.</creatorcontrib><creatorcontrib>Spyridaki, Aikaterini</creatorcontrib><creatorcontrib>Savva, Athina</creatorcontrib><creatorcontrib>Georgitsi, Marianna</creatorcontrib><creatorcontrib>Tsaganos, Thomas</creatorcontrib><creatorcontrib>Mouktaroudi, Maria</creatorcontrib><creatorcontrib>Raftogiannis, Maria</creatorcontrib><creatorcontrib>Antonopoulou, Anastasia</creatorcontrib><creatorcontrib>Papaziogas, Vassilios</creatorcontrib><creatorcontrib>Baziaka, Fotini</creatorcontrib><creatorcontrib>Sereti, Kalliopi</creatorcontrib><creatorcontrib>Christopoulos, Petros</creatorcontrib><creatorcontrib>Marioli, Androniki</creatorcontrib><creatorcontrib>Kanni, Theodora</creatorcontrib><creatorcontrib>Maravitsa, Panagiota</creatorcontrib><creatorcontrib>Pantelidou, Ilianna</creatorcontrib><creatorcontrib>Leventogiannis, Konstantinos</creatorcontrib><creatorcontrib>Tsiaoussis, Panagiotis</creatorcontrib><creatorcontrib>Lymberopoulou, Korina</creatorcontrib><creatorcontrib>Koutelidakis, Ioannis M.</creatorcontrib><creatorcontrib>Second Department of Surgery</creatorcontrib><creatorcontrib>Medical School</creatorcontrib><creatorcontrib>Second Department of Internal Medicine</creatorcontrib><creatorcontrib>University of Athens</creatorcontrib><creatorcontrib>Fourth Department of Internal Medicine</creatorcontrib><creatorcontrib>University of Thessaloniki</creatorcontrib><creatorcontrib>"Sismanogleion" Athens Hospital</creatorcontrib><title>Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>One prospective, open-label, non-randomized study was conducted in 100 patients to define the antipyretic and analgesic effect of a new intravenous formulation of 1 g of paracetamol; 71 received paracetamol for the management of fever and 29 received paracetamol for pain relief after abdominal surgery or for neoplastic pain. Serial follow-up measurements of core temperature and of pain intensity were done for 6 h. Additional rescue medications were recorded for 5 days. Blood was sampled for the measurement of free paracetamol (APAP) and of glucuronide-APAP and N-sulfate-APAP by an HPLC assay. Defervescence, defined as core temperature below or equal to 37.1°C, was achieved in 52 patients (73.2%) within a median time of 3 h. Patients failing to become afebrile with the first dose of paracetamol became afebrile when administered other agents as rescue medications. Analgesia was achieved in 25 patients (86.4%) within a median time of 2 h. Serum levels of glucuronide-APAP were greater among non-responders to paracetamol. The presented results suggest that the intravenous formulation of paracetamol is clinically effective depending on drug metabolism.</description><subject>Abdominal Pain - drug therapy</subject><subject>Acetaminophen - administration & dosage</subject><subject>Acetaminophen - blood</subject><subject>Acetaminophen - metabolism</subject><subject>Acetaminophen - pharmacokinetics</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>analgesia</subject><subject>Female</subject><subject>fever</subject><subject>Fever - drug therapy</subject><subject>Fever - etiology</subject><subject>Humans</subject><subject>Infection - complications</subject><subject>Infusions, Intravenous</subject><subject>Interleukin-6 - blood</subject><subject>intravenous paracetamol</subject><subject>Male</subject><subject>Middle Aged</subject><subject>pain</subject><subject>Pain, Intractable - drug therapy</subject><subject>Pain, Postoperative - drug therapy</subject><subject>Prospective Studies</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFkc1vFCEYxidGY2v15tnM0YNb-RzAW9PaukmNTdQzYZh3ZtnMwApsk_73sjvbOZnIAd4Xfnl44Kmq9xhdYsLZ5-1uky4xxZTePryozjFlYiUbJl8uNaZn1ZuUtggRiXDzujojjHPKED2vhrXP0TyCD_tUP5hoLGQzhbE2qTa-vvLZ7Z4iZGdL25XejAOk0n2HzlmTXfBf6ryB-qcbvOvLlrdQh76-ifuhQNm0YXRpelu96s2Y4N1pvah-3379df1tdf_jbn19db-yQrC86pW1FhAWxatQxDSNwm3X8eK3F60khVJMqE41BEHT8lZCR6htcIeJUqqnF9V61u2C2epddJOJTzoYp48bIQ7axPKaEXTLCZaSda1VHVOEqRbzHig2YA0RtC1aH2etXQx_9pCynlyyMI7GQ_kujSUVFFEi5P9RjjAVQjZNQT_NqI0hpQj94hIjfUhUHxLVp0QL_uGkvG8n6Bb4OcIC3M3AdExkDH50HvQ27GMJK2nbN8k68JogzDTChCGiEeKlZIeekzKkILwo3cxK25TNAMtVzx82-yJMk-N8crgc242JGnyRaWYZKDk_Ooj6eL8t9iLYXIJw_37qX3Ig3N4</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Giamarellos-Bourboulis, Evangelos J.</creator><creator>Spyridaki, Aikaterini</creator><creator>Savva, Athina</creator><creator>Georgitsi, Marianna</creator><creator>Tsaganos, Thomas</creator><creator>Mouktaroudi, Maria</creator><creator>Raftogiannis, Maria</creator><creator>Antonopoulou, Anastasia</creator><creator>Papaziogas, Vassilios</creator><creator>Baziaka, Fotini</creator><creator>Sereti, Kalliopi</creator><creator>Christopoulos, Petros</creator><creator>Marioli, Androniki</creator><creator>Kanni, Theodora</creator><creator>Maravitsa, Panagiota</creator><creator>Pantelidou, Ilianna</creator><creator>Leventogiannis, Konstantinos</creator><creator>Tsiaoussis, Panagiotis</creator><creator>Lymberopoulou, Korina</creator><creator>Koutelidakis, Ioannis M.</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope><scope>DOA</scope></search><sort><creationdate>2014</creationdate><title>Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism</title><author>Giamarellos-Bourboulis, Evangelos J. ; Spyridaki, Aikaterini ; Savva, Athina ; Georgitsi, Marianna ; Tsaganos, Thomas ; Mouktaroudi, Maria ; Raftogiannis, Maria ; Antonopoulou, Anastasia ; Papaziogas, Vassilios ; Baziaka, Fotini ; Sereti, Kalliopi ; Christopoulos, Petros ; Marioli, Androniki ; Kanni, Theodora ; Maravitsa, Panagiota ; Pantelidou, Ilianna ; Leventogiannis, Konstantinos ; Tsiaoussis, Panagiotis ; Lymberopoulou, Korina ; Koutelidakis, Ioannis M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c774t-f9ccce017002792a6691bdd5455f7b82c779479d9620e6b5b8ed23c61d12999f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abdominal Pain - drug therapy</topic><topic>Acetaminophen - administration & dosage</topic><topic>Acetaminophen - blood</topic><topic>Acetaminophen - metabolism</topic><topic>Acetaminophen - pharmacokinetics</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>analgesia</topic><topic>Female</topic><topic>fever</topic><topic>Fever - drug therapy</topic><topic>Fever - etiology</topic><topic>Humans</topic><topic>Infection - complications</topic><topic>Infusions, Intravenous</topic><topic>Interleukin-6 - blood</topic><topic>intravenous paracetamol</topic><topic>Male</topic><topic>Middle Aged</topic><topic>pain</topic><topic>Pain, Intractable - drug therapy</topic><topic>Pain, Postoperative - drug therapy</topic><topic>Prospective Studies</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giamarellos-Bourboulis, Evangelos J.</creatorcontrib><creatorcontrib>Spyridaki, Aikaterini</creatorcontrib><creatorcontrib>Savva, Athina</creatorcontrib><creatorcontrib>Georgitsi, Marianna</creatorcontrib><creatorcontrib>Tsaganos, Thomas</creatorcontrib><creatorcontrib>Mouktaroudi, Maria</creatorcontrib><creatorcontrib>Raftogiannis, Maria</creatorcontrib><creatorcontrib>Antonopoulou, Anastasia</creatorcontrib><creatorcontrib>Papaziogas, Vassilios</creatorcontrib><creatorcontrib>Baziaka, Fotini</creatorcontrib><creatorcontrib>Sereti, Kalliopi</creatorcontrib><creatorcontrib>Christopoulos, Petros</creatorcontrib><creatorcontrib>Marioli, Androniki</creatorcontrib><creatorcontrib>Kanni, Theodora</creatorcontrib><creatorcontrib>Maravitsa, Panagiota</creatorcontrib><creatorcontrib>Pantelidou, Ilianna</creatorcontrib><creatorcontrib>Leventogiannis, Konstantinos</creatorcontrib><creatorcontrib>Tsiaoussis, Panagiotis</creatorcontrib><creatorcontrib>Lymberopoulou, Korina</creatorcontrib><creatorcontrib>Koutelidakis, Ioannis M.</creatorcontrib><creatorcontrib>Second Department of Surgery</creatorcontrib><creatorcontrib>Medical School</creatorcontrib><creatorcontrib>Second Department of Internal Medicine</creatorcontrib><creatorcontrib>University of Athens</creatorcontrib><creatorcontrib>Fourth Department of Internal Medicine</creatorcontrib><creatorcontrib>University of Thessaloniki</creatorcontrib><creatorcontrib>"Sismanogleion" Athens Hospital</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giamarellos-Bourboulis, Evangelos J.</au><au>Spyridaki, Aikaterini</au><au>Savva, Athina</au><au>Georgitsi, Marianna</au><au>Tsaganos, Thomas</au><au>Mouktaroudi, Maria</au><au>Raftogiannis, Maria</au><au>Antonopoulou, Anastasia</au><au>Papaziogas, Vassilios</au><au>Baziaka, Fotini</au><au>Sereti, Kalliopi</au><au>Christopoulos, Petros</au><au>Marioli, Androniki</au><au>Kanni, Theodora</au><au>Maravitsa, Panagiota</au><au>Pantelidou, Ilianna</au><au>Leventogiannis, Konstantinos</au><au>Tsiaoussis, Panagiotis</au><au>Lymberopoulou, Korina</au><au>Koutelidakis, Ioannis M.</au><aucorp>Second Department of Surgery</aucorp><aucorp>Medical School</aucorp><aucorp>Second Department of Internal Medicine</aucorp><aucorp>University of Athens</aucorp><aucorp>Fourth Department of Internal Medicine</aucorp><aucorp>University of Thessaloniki</aucorp><aucorp>"Sismanogleion" Athens Hospital</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2014</date><risdate>2014</risdate><volume>124</volume><issue>2</issue><spage>144</spage><epage>152</epage><pages>144-152</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>One prospective, open-label, non-randomized study was conducted in 100 patients to define the antipyretic and analgesic effect of a new intravenous formulation of 1 g of paracetamol; 71 received paracetamol for the management of fever and 29 received paracetamol for pain relief after abdominal surgery or for neoplastic pain. Serial follow-up measurements of core temperature and of pain intensity were done for 6 h. Additional rescue medications were recorded for 5 days. Blood was sampled for the measurement of free paracetamol (APAP) and of glucuronide-APAP and N-sulfate-APAP by an HPLC assay. Defervescence, defined as core temperature below or equal to 37.1°C, was achieved in 52 patients (73.2%) within a median time of 3 h. Patients failing to become afebrile with the first dose of paracetamol became afebrile when administered other agents as rescue medications. Analgesia was achieved in 25 patients (86.4%) within a median time of 2 h. Serum levels of glucuronide-APAP were greater among non-responders to paracetamol. The presented results suggest that the intravenous formulation of paracetamol is clinically effective depending on drug metabolism.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>24553403</pmid><doi>10.1254/jphs.13133FP</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-8613 |
ispartof | Journal of Pharmacological Sciences, 2014/02/20, Vol.124(2), pp.144-152 |
issn | 1347-8613 1347-8648 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_b521884dbc9d49249b15fe31aeca273b |
source | ScienceDirect® |
subjects | Abdominal Pain - drug therapy Acetaminophen - administration & dosage Acetaminophen - blood Acetaminophen - metabolism Acetaminophen - pharmacokinetics Adolescent Adult Aged analgesia Female fever Fever - drug therapy Fever - etiology Humans Infection - complications Infusions, Intravenous Interleukin-6 - blood intravenous paracetamol Male Middle Aged pain Pain, Intractable - drug therapy Pain, Postoperative - drug therapy Prospective Studies Treatment Outcome Young Adult |
title | Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T08%3A15%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20Paracetamol%20as%20an%20Antipyretic%20and%20Analgesic%20Medication:%20the%20Significance%20of%20Drug%20Metabolism&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Giamarellos-Bourboulis,%20Evangelos%20J.&rft.aucorp=Second%20Department%20of%20Surgery&rft.date=2014&rft.volume=124&rft.issue=2&rft.spage=144&rft.epage=152&rft.pages=144-152&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.13133FP&rft_dat=%3Cproquest_doaj_%3E1837303278%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c774t-f9ccce017002792a6691bdd5455f7b82c779479d9620e6b5b8ed23c61d12999f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1501377866&rft_id=info:pmid/24553403&rfr_iscdi=true |